Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
The Role of Notch Signaling in the Pathogenesis of Multiple Sclerosis
EF 2018-19
Résumé
Multiple sclerosis is an autoimmune disease that is characterized by the destruction of myelin in the central nervous system (CNS) by immune cells recognizing self-antigen. The main driver of the demyelination activity are subtypes of T helper (Th) cell, particularly Th1 and Th17 cells, which recruit other immune cells to cause damage to the CNS. There is some evidence that Notch signaling regulates the differentiation and proliferation of Th1 and Th17 cells during multiple sclerosis. However, the exact role that Th1 and Th17 cells play and the disease progression stage at which Notch signaling is critical for Th1 and Th17 cells development are still unclear.
Thus, the aims of my project are to identify the role that Th1 and Th17 cells play in multiple sclerosis, what other populations of immune cells also cause damages to the CNS, and when does Notch signaling play a critical role in disease establishment and relapse. My hypothesis is stage-specific modulation of Notch signaling in T cells will lead to different disease severities or amelioration in combination with the local immune microenvironment.
To address my hypothesis, I will analyze the impact of Notch signaling in Th1 and Th17 cell responses in the development of multiple sclerosis. I will also determine the role Notch signaling plays in the activation of other immune cell populations during disease development.
By answering these questions, my project aims to provide a better understanding of disease development and immune cell functions in the establishment of the disease, which will ultimately provide further insights for more selective and effective therapies for multiple sclerosis.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
406388
Name
Wang Helen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Role of Notch Signaling in the Pathogenesis of Multiple Sclerosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmune Disease; Central Nervous System; Multiple Sclerosis; Notch Signaling; T Cell Response
Abstract
Multiple sclerosis is an autoimmune disease that is characterized by the destruction of myelin in the central nervous system (CNS) by immune cells recognizing self-antigen. The main driver of the demyelination activity are subtypes of T helper (Th) cell, particularly Th1 and Th17 cells, which recruit other immune cells to cause damage to the CNS. There is some evidence that Notch signaling regulates the differentiation and proliferation of Th1 and Th17 cells during multiple sclerosis. However, the exact role that Th1 and Th17 cells play and the disease progression stage at which Notch signaling is critical for Th1 and Th17 cells development are still unclear.
Thus, the aims of my project are to identify the role that Th1 and Th17 cells play in multiple sclerosis, what other populations of immune cells also cause damages to the CNS, and when does Notch signaling play a critical role in disease establishment and relapse. My hypothesis is stage-specific modulation of Notch signaling in T cells will lead to different disease severities or amelioration in combination with the local immune microenvironment.
To address my hypothesis, I will analyze the impact of Notch signaling in Th1 and Th17 cell responses in the development of multiple sclerosis. I will also determine the role Notch signaling plays in the activation of other immune cell populations during disease development.
By answering these questions, my project aims to provide a better understanding of disease development and immune cell functions in the establishment of the disease, which will ultimately provide further insights for more selective and effective therapies for multiple sclerosis.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wang, Helen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~